YMAB: Y-mAbs Therapeutics, Inc. Stock

by  •  • Comments Off on YMAB: Y-mAbs Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 205.29
Enterprise Value ($M) 138.06
Book Value ($M) 92.00
Book Value / Share 2.03
Price / Book 2.23
NCAV ($M) 70.61
NCAV / Share 1.56
Price / NCAV 2.91

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.24
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 3.85
Current Ratio 4.16

Balance Sheet (mrq) ($M)
Current Assets 98.51
Assets 119.90
Liabilities 27.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 87.69
Operating Income -25.11
Net Income -29.67
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -15.71
Cash from Investing 0.00
Cash from Financing 4.31

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Paradigm Biocapital Advisors LP 9.20 85.89
11-12 13G/A Vanguard Group Inc 4.56 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-04 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 17,276 92,300 18.72
2025-04-16 47,657 245,792 19.39
2025-04-15 38,887 245,327 15.85
2025-04-14 34,249 169,830 20.17

(click for more detail)

Similar Companies
XBIT – XBiotech Inc. XERS – Xeris Biopharma Holdings, Inc.
XLO – Xilio Therapeutics, Inc. ZVRA – Zevra Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io